These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Levamisole -- a drug modifying immunologic phenomena]. Bogdanikowa B Postepy Hig Med Dosw; 1979; 33(2):125-46. PubMed ID: 384382 [No Abstract] [Full Text] [Related]
5. [Experimental study in the rat of aspects of the immunomodulating activity of levamisole. 2. The effects of levamisole on immune phagocytosis assessed in vivo and in vitro]. Gorini P; Corridori S; Scevola D; Marone P; Vender A Riv Emoter Immunoematol; 1979; 26(1-2):1-15. PubMed ID: 554313 [No Abstract] [Full Text] [Related]
6. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report. Gordon BL; Keenan JP Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857 [TBL] [Abstract][Full Text] [Related]
7. [Levamisole as an immunoregulatory drug]. Górska M Pol Tyg Lek; 1979 Apr; 34(14):553-5. PubMed ID: 377261 [No Abstract] [Full Text] [Related]
8. [Levamisole--an attempt at immunomodulating treatment of inflammatory and autoimmune nervous system diseases]. Cendrowski W Pol Tyg Lek; 1977 Aug; 32(31):1211-3. PubMed ID: 331285 [No Abstract] [Full Text] [Related]
10. [Experiments in the rat showing aspects of the immunomodulating activity of levamisole. 1) Effect of levamisole on antibody production and on the phenomenon of specific immune cytoadherence]. Gorini P; Corridori S; Scevola D; Marone P; Vender A Riv Emoter Immunoematol; 1978; 25(5-6):223-33. PubMed ID: 555029 [No Abstract] [Full Text] [Related]
11. [Effects of levamisole and D-penicillamine on immunologically responsible cells]. Ogawa K; Tsubura E Nihon Rinsho; 1981 Apr; 39(4):1902-8. PubMed ID: 7031299 [No Abstract] [Full Text] [Related]
12. Levamisole as an immunotherapeutic agent in the treatment of cancer. Amery WK World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084 [No Abstract] [Full Text] [Related]
13. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole]. Vatin AE; Filatov PP Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414 [TBL] [Abstract][Full Text] [Related]
14. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations. Balaram P; Padmanabhan TK; Vasudevan DM Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681 [TBL] [Abstract][Full Text] [Related]
15. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered. Faanes RB; Dillon P; Choi YS Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166 [TBL] [Abstract][Full Text] [Related]
17. [Effect of levamisole on white mice and on the immunological reactivity of guinea pigs]. Bonovska M; Kostov G Vet Med Nauki; 1985; 22(5):32-6. PubMed ID: 4035985 [TBL] [Abstract][Full Text] [Related]
18. [Effect of levamisole on phagocytosis and the functional state of the T- and B-lymphocytes in children with kidney diseases]. Stefani DV; Sikharulidze GI; Fokeeva VV; Korovina NA; Zernov IN Pediatriia; 1980 Nov; (11):52-3. PubMed ID: 6969390 [No Abstract] [Full Text] [Related]
19. The reticuloendothelial system, cancer and cancer immunotherapy. Amery WK J Reticuloendothel Soc; 1977 Jun; 21(6):417-21. PubMed ID: 886546 [No Abstract] [Full Text] [Related]
20. [Therapeutic effectiveness of a T-cell stimulant, levamisole, in certain diseases in children]. Sidel'nikov VM; Afana'ev EN; Pomytkina LR Pediatr Akus Ginekol; 1978; (5):13-4. PubMed ID: 362353 [No Abstract] [Full Text] [Related] [Next] [New Search]